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ABSTRACT 
Few prospective studies have investigated the patient-reported outcome measures (PROM) 
in patients less than 70 years that sustained a femoral neck fracture (FNF) treated with 
closed reduction and internal fixation (CRIF). The health-related quality of life (HRQoL) 
using the self-administered questionnaires EuroQol 5 Dimension (EQ-5D) and Short Form-
36 Health Survey (SF-36) and with a long term follow-up has not previously been 
examined in this group of patients. 
Factors associated with healing complications leading to a major re-operation with a total 
hip replacement as well as mortality has not been investigated for this group.  
The ability of the questionnaires EQ-5D and SF-36 to reveal clinical important changes in 
health over time, the so called responsiveness, has not been studied for patients younger 
than 70 years with a FNF. 
The comprehensive goal of this thesis was to investigate the HRQoL, functional outcome, 
factors associated with a major re-operation as well as mortality with a 4, 12, 24-month and 
10-year follow-up in patients 20-69 years that sustained a FNF treated with CRIF. Another 
aim was to determine the responsiveness of EQ-5D and SF-36 in this specific group of 
patients. 
 
Methods:  
Study I: 182 patients with displaced and non-displaced FNF were included in a prospective 
multicenter study. At each follow-up, clinical and radiographic examinations were 
performed at 4, 12 and 24 months. Gathered data included HRQoL (EQ-5D and SF-36), hip 
function according to Harris Hip Score (HHS), fracture healing complications such as non-
union (NU) and avascular necrosis (AVN), co-morbidities and major re-operations with a 
hip arthroplasty. 	 
Study II: 128 patients from the same cohort as Study I with a displaced FNF were included. 
At inclusion, bone mineral density (BMD) was measured by DXA.	A logistic regression 
was performed to find associated variables with a re-operation due to NU or AVN detected 
at 4, 12 and 24-months follow-up. 	
Study III: A 10-year follow-up of the cohort in Study I. The hip function was assessed using 
the Hip Disability Outcome Score (HOOS) and HRQoL was evaluated using the EQ-5D 
questionnaire. Deceased patients had the date of death recorded and associated factors with 
mortality were analyzed by regression logistic calculation of baseline data. 
Study IV: The responsiveness of the HRQoL instruments SF-36 and EQ-5D was evaluated 
by estimating the standardized effect size (SES), standardized response mean (SRM), 
receiver operating characteristic curve (ROC) and area under the curve (AUC). 
 
Results:  
Study I: At 24 months, the hip function according to HHS in patients with a displaced 
fracture showed a good or excellent score in 73% and in those with a non-displaced fracture 
85% (p = 0.15). EQ-5D and SF-36 were the lowest at 4 months and improved at 12 and 24 
months but did not regain pre-fracture level (p<0.01) regardless of fracture type. Patients 
with a displaced FNF had a NU in 23% of the cases, AVN in 15% and a total of 28% had a 
major re-operation. No patients with a non-displaced FNF developed NU, 12% developed 
an AVN and a total of 8% had a major re-operation with a total hip replacement (THR). 
Study II: The rate of a major re-operation was 6%, 16% and 28% at 4, 12 and 24 months. 
Patients having a low BMD (OR 5.5, CI 1.1-27) and harmful alcohol consumption (OR 3.2, 
CI 1.2-8.8) were more likely to undergo a major re-operation due to NU or AVN. 
Study III: From initial 182 included patients, a total of 88 patients participated. The EQ-5D 
improved compared to 24-month follow-up (p=0.006). However, the EQ-5D did not 
recover to the pre-fracture level (p<0.001). The score, however was equivalent to 
population data of Sweden. Factors associated with mortality at 10 years were higher age, 
co-morbidity, osteoporosis and smoking.  
Study IV: SES at 4 months was large for EQ-5D and SF-36 and moderate at 12- and 24-
month follow-up. The correlation between the changes in HHS (4–24 months) and HRQoL 
were moderate to weak but the correlation between total scores were strong. The ability to 
predict and follow the external standard as well as the effect sizes implies that the internal 
and external responsiveness of SF-36 and EQ-5D were good.  
 
Conclusion: 
The functional outcome was good or excellent in more than two thirds and the HRQoL 
continues to improve up to 10 years after sustaining a FNF in patients younger than 70 
years treated with CRIF. However, the HRQoL did not reach the level before fracture, 
probably because all included subjects were 10 years older. The EQ-5D at 10-year follow-
up were equivalent to sex- and age-matched reference population in Sweden. The majority 
of the patients with a displaced FNF healed and less than 10% of patients with a non-
displaced FNF underwent a major re-operation. A low BMD and harmful alcohol 
consumption according to AUDIT increased the risk for undergoing a major re-operation 
with a total hip replacement.  One third of the patients were deceased 10 years later and 
they were more compromised with illnesses and smoking comparing to surviving subjects. 
The HRQoL questionnaires EQ-5D and SF-36 were both responsive for changes in health 
over time.  EQ-5D was easier to administer and can be used alone compared to the more 
complex and time-consuming SF-36.  
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1 THESIS AT A GLANCE 
 
I. Good functional outcome but not regained health related quality of life in the 
majority of 20-69 years old patients with femoral neck fracture treated with internal 
fixation- A prospective 2-year follow-up study of 182 patients.                                       
How was the HRQoL and hip function affected and to what extend did the fracture heal 
after a FNF in patients younger than 70 years treated with CRIF?                                 
Patients: 182 patients with a FNF both displaced and non-displaced.                             
Method: Data of ASA, EQ-5D, SF-36, HHS and major re-operation were collected as well 
as radiological examinations at 4,12 and 24-month follow-up.                                      
Conclusion: EQ-5D, SF-36 and HHS were at the lowest at 4-month follow-up and highest 
at 24-month follow-up, but the level of pre-fracture was not reached. Two thirds of the 
patients had good or excellent hip function according to HHS at 24-month follow-up. A 
third of the patients with displaced FNF underwent a major re-operation. 
II. Low BMD and high alcohol consumption predict a major re-operation in patients 
younger than 70 years of age with a displaced femoral neck fracture- A two- year 
follow up study in 120 patients.  
Are there any predictors of failed fracture healing?        
Patients: 120 patients with a displaced FNF. 
Method: A DXA at inclusion, ASA and co-morbidities were collected and a logistic 
regression was performed to find variables associated with a major re-operation caused by a 
non-union or avascular necrosis at 24-months follow-up.		
Conclusion: A low BMD and harmful alcohol drinking elevates the risk of a major re-
operation. 		                                                                                             	
 
III. Health related quality of life and mortality 10 years after a femoral neck fracture 
in patients younger than 70 years.   
How was the HRQoL and hip function affected and what factors were correlated with 
mortality 10 years after a FNF?  
Patients: 88 patients with both displaced and non-displaced FNF participated through self-
administered questionnaires. 170 patients participated in the mortality analysis. 
Method: The EQ-5D was compared with previous results and hip function was assessed 
according to HOOS. Factors associated with mortality were analyzed by regression logistic 
calculation of baseline data of co-morbidities, DXA and life-style factors. 
Conclusion: The functional outcome and HRQoL continues to improve up to 10 years after 
a FNF but the pre-fracture levels were not regained. One third of the patients were deceased 
and factors associated with mortality 10 years later were higher age, co-morbidity, 
osteoporosis and smoking.  
 
IV. Good responsiveness with EuroQol 5-Dimension questionnaire and Short Form 
(36) Health Survey in 20–69 years old patients with a femoral neck fracture: A 2-year 
prospective follow-up study in 182 patients.  
Were EQ-5D and SF-36 responsive in measuring the change in HRQoL over time in 
patients less than 70 years that sustained a FNF treated with CRIF. 
Patients: 182 patients with a FNF both displaced and non-displaced. 
Method: Data of EQ-5D and SF-36 were collected at 4,12 and 24-month follow-up. The 
responsiveness was evaluated.  
Conclusion: EQ-5D and SF-36 were both responsive in their capacity to detect subjective 
improvements or worsening in health after a FNF.                        
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2 INTRODUCTION  
 
Background  
The incidence of hip fractures in Sweden is around 16000 annually and the average age 
among these patients is 80 years [1]. Of all patients sustaining a hip fracture, less than 3% 
are younger than 50 years [2,3]. Hip fractures are classified according to X-ray findings 
whether the line of fracture goes through the cervical neck (Figure 1) or through the 
trochanteric area [4]. The femoral neck fractures (FNF) that constitutes about 50% of all hip 
fracture [1] are divided into non-displaced and displaced fracture according to the Garden 
classification (Figure 2) [5].  
 
 
 
Figure 1. X-ray demonstrating a displaced femoral neck fracture. 
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                                               Figure 2. Garden classification I-IV. 
 
 
Diagnosis and treatment 
Diagnosis of a FNF, Garden classification, the postoperative surgical results as well as 
healing complications such as non-union (NU) or avascular necrosis (AVN) are assessed by 
an X-ray taken from two angles: anterior-posterior and a lateral projection [4,5]. 
 The majority of patients with a FNF undergo surgery with either closed fracture reduction 
and internal fixation (CRIF) (Figure 3) or a hip replacement [1,2,6]. The choice of 
operating method depends on the patient’s age, type of fracture and the patient´s medical 
condition [7]. CRIF is the choice of surgical method in patients above 70 years of age if the 
FNF is non-displaced (Garden 1-2) [1] and in patients less than 65-70 years regardless of 
degree of displacement [2,6]. The desire to preserve the native hip joint is the rationale 
behind this recommendation which may facilitate the patients´ future functional demand 
[8]. The life expectancy in these patients is longer and therefore the risk of surgical revision 
is increased if operated with hip a prosthesis [9].  
During the last 10 years CRIF has gradually been replaced by hip replacement in patients 
above 70 years with a displaced FNF [1]. Only 2% of all displaced FNF were treated with a 
hip replacement in 1988 and 86% in 2017 [1]. 
However, in Sweden an increasing number of patients younger than 70 years suffering from 
a displaced FNF are treated with total hip replacement (THR) [1]. Another study showed 
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the same trend in the USA using the American Board of Orthopaedic Surgery database 
where 13% of patients younger than 65 years were treated with a THR compared to only 
1%, twelve years earlier [10].  
 
 
                           Figure 3. A FNF treated with CRIF. 
 
Healing complications 
Different studies have shown fewer healing complications in elderly when displaced FNF 
are treated with hip replacement rather than CRIF resulting in less than 10% of surgical 
failure [11,12,13]. Displaced FNF treated with IF has a surgical complication frequency of 
40-50% in elderly [8,11,14,15,16]. Most common complications are NU and AVN 
[8,11,14]. NU leads to a re-displacement of the fracture and displacement of the screws 
[11]. A re-operation is then usually done with a hip replacement [17]. About half of those 
patients developing AVN do not have any substantial effect on hip function and may not 
need a re-operation [18,19]. Patients with symptoms from AVN often undergo a re-
operation with a THR [20]. 
Studies showing a high rate of healing complication have evaluated the results in patients 
with an average age of 80 years [11,12]. Patients 50-70 years of age have rarely been 
studied separately and are often added to the group of elderly patients [2]. Long time 
prospective studies in younger patients are lacking and The National Hip fracture registry in 
Sweden has a follow-up period of only four months and does not focus on re-operations [1].  
 
Risk factors for healing complications 
Studies analyzing variables connected to a re-operation due to healing complications are 
few in younger patients younger than 70 years with a FNF [21]. The blood supplying the 
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femoral head may be affected due to an altered anatomical structure such as fracture 
displacement and posterior comminution and may lead to AVN or NU [22].  
A study by Lindequist et al showed that a screw position that is suboptimal is significantly 
related to the development of NU [23]. Other studies showed that patients younger than 70 
years having a fair or poor fracture reduction have significantly higher frequency of re-
operation [6,24]. A study by Parker et al including patients age 60-80 years reported an 
increased risk of re-operation in female patients with a FNF regardless of age [25]. 
 
Several studies have demonstrated an elevated risk for fracture-healing complications in 
patients having a low bone mineral density (BMD) [26,27,28], while another study did not 
find such relationship [29]. A low BMD has shown to impede fracture heeling which has 
been seen in several studies [30,31]. Osteoporosis appears to delay callus maturation and 
therefore affecting fracture healing [30] and the strength of fixation of an implant will be 
affected due to altered trabecular and cortical bone structure [31]. No study has investigated 
the effect of low BMD on the prevalence of healing complications in patients younger than 
70 years having a FNF.  
 
Bone mineral density measurements in the study 
Dual energy X-ray absorptiometry (DXA) is an X-ray of low radiation with a capacity to 
detect small percentage of bone loss since absorption of radiation is sensitive to calcium 
content in the skeleton [32]. DXA is used to measure the bone density in the spine, hip and 
the whole skeleton [33].  Information of BMD provides a diagnostic criteria and can be 
followed for both treated and untreated patients and provide prognostic information on the 
probability of future fractures [32]. By densitometric techniques the BMD which is the 
amount of bone mass per unit area (areal density) or per unit volume (volumetric density), 
can be estimated in vivo [32]. The results are given in the two measures, T-score and Z-
score [33].  The score indicates the amount the subject’s BMD varies from the mean.  A 
positive score indicates a higher BMD and a negative scores indicate a lower BMD [33]. 
The T-score is the relevant measure when screening for osteoporosis since the BMD at the 
site of the subject is compared to normal mean value of young reference group [33]. The T-
score compares the actual patient’s BMD with healthy 30-year-old Caucasian female´s 
BMD at the femoral neck and used in post-menopausal women and men above 50 years of 
age. The same diagnostic criteria using a female reference range is used in men [33]. The 
criteria as stated in World Health Organization (WHO) in the diagnosis of osteoporosis is a 
T-score value ≤ −2.5 SD [34]. A T-score value ≥ −1 SD is regarded as normal and T-score 
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between < −1 and > −2.5 SD is regarded as osteopenia [34]. The Z-score compares the 
subjects BMD with age-matched reference group and used in cases of severe osteoporosis, 
in men younger than 50 years, premenopausal women and in children [34]. The Z-score 
shows the difference of the standard deviation of the patient's BMD from the average BMD 
of their sex, age, and ethnicity [34]. A Z-score below −2 SD in young patients (20–
49 years), is regarded as a low BMD stated in the International Society of Clinical 
Densitometry [35].  
 
Alcohol use disorder identification test used in the study 
Alcoholism has in one earlier study shown to be a significant predictor of surgical failure 
due to AVN and NU in patients younger than 60 years of age with a hip fracture [6].  
High alcohol consumption affects bone metabolism and thereby BMD [36,37], contribute to 
malnutrition, increase the tendency to fall and causing comorbidities [38] that all may affect 
the risk for a re-operation.  
 
Alcohol use disorder identification test (AUDIT) is an instrument validated to identify 
harmful alcohol consumption and dependence [39]. It has 10 questions in which each 
question has a score of 0-4 points. An indication of harmful drinking is a score of ≥ 8 in 
men and ≥ 5 in women [39].  
 
Health-Related Quality of Life  
The surgical outcome has by tradition been evaluated by general or surgical postoperative 
complications [2,7,19,26]. However, the patient´s Health-related quality of life (HRQoL) 
and function postoperatively might be more relevant to evaluate in these younger patients 
with a hip fracture [21]. Elderly patients with a FNF often get a reduced HRQoL that 
persists for a long time [11]. There are several generic instruments for measuring the 
HRQoL by evaluating the patient-reported outcome measure (PROM) [40]. PROMs are 
divided into generic or disease-specific [40]. 
Two of the generic PROM questionnaires are EuroQol 5-Dimension (EQ-5D) and Short 
Form (36) Health Survey (SF-36) [41,42]. In elderly having a hip fracture, the EQ-5D and 
SF-36 have in several studies evaluated the outcome of HRQoL and has been found to be 
both valid and responsive [43,44,45,46,47,48]. The outcome of HRQoL and the 
responsiveness of SF-36 and EQ-5D have not previously been studied in patients younger 
than 70 years having a FNF. 
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Short form 36 
SF-36 has eight different domain scales with 36 items. The first four domains are the SF-36 
physical scale; role-physical (RP), physical functioning (PF), general health (GH) and 
bodily pain (BP). The score of these questions are added and then divided by four in order 
to get the SF-36 physical score which has a spectrum from 0-100. The last four questions 
are the SF-36 mental scale; vitality (VT), role-emotional (RE), social functioning (SF), and 
mental health (MH). By adding the scores and dividing by four the SF-36 mental score is 
calculated. The SF-36 total score is estimated by adding all scores from the eight questions 
and divide by eight [41].  
 
The 5-dimensional scale of the EuroQol  
EQ-5D has two parts; a visual analogue scale (VAS), and a questionnaire composed of five 
questions regarding five different dimensions; Mobility, Self-care, Usual activities, 
Pain/Discomfort and Anxiety/Depression. An index score from the response is calculated in 
which 1 corresponds to full health and 0 the worst possible health [41]. In order to 
determine values for 243 possible health states, the time trade off (TTO) method has been 
used in which the respondents were asked how many years in the current health they would 
trade off, in order to regain full health if they had 10 years left to live [49]. Dolan et al 
developed the frequently used UK description-based method [49] in which the responders 
were described which condition they had thus giving hypothetical values [49]. Burström et 
al developed a new set of values that is based on a Swedish population and instead of a 
description based method, an experience-based method was used in which the responders 
replied according to their own current health [50]. The description-based method is 
considered inferior to experience-based method since it’s not affected by possible 
adaptation to changes in health [51]. The Swedish value set is more accurate in a Swedish 
population with a THR compared to the UK set [50]. A disadvantage of the Swedish value 
set is that it is harder to compare the results with older but similar studies that uses the UK 
method [51]. 
 
Responsiveness of EQ-5D and SF-36                  
The definition of responsiveness of an instrument is the capability to distinguish clinical 
changes over time in a specified condition and the responsivenss is an important part of 
validating an instrument [52]. The responsiveness may be divided into an internal and an 
external responsiveness [53]. The internal responsiveness represents the capability of an 
instrument to distinguish changes over a time frame and can be expressed in three ways: 
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change score, standardized effect size (SES) and standardized response mean (SRM) [53]. 
Change score is defined as the mean change in score between two measures or more in the 
same group of patients [53]. If the change score is of clinical significance the value is 
compared to minimally important difference (MID) [53]. The definition of MID is the mean 
change in score between two measures in which the patients reports a change (positive or 
negative) in their health [53]. The SES is calculated by dividing mean change score and SD 
of the baseline score [54]. The SRM is calculated by dividing mean change score and SD of 
the change score. Results are then evaluated by the Cohen´s threshold: large (>0.8), 
moderate (0.8-0.5) and small (<0.5) [54]. 
External responsiveness reflects the degree in which a change in a measure corresponds to   
changes in a reference measure of health or a clinical status [53].   
To analyze the external responsiveness an external criterion (EC) is necessary to produce 
for example using a self-related health (SRH) question [53], early complications [44] or 
fracture displacement [43]. A dichotomized ECs can then be created suitable for Receiver 
operating characteristics (ROC) analysis as well as Area under the curve (AUC) 
calculations [55]. This allows an illustration of the sensitivity and specificity of a measure 
to detect subjective changes in health [55]. The external responsiveness can also be 
analyzed by calculating correlations between different instruments.  
 
Ceiling and floor effects on EQ-5D and SF-36            
A ceiling effect happens when a high proportion of the patients receive the highest scores 
when performing a test. Therefore, discrimination between patients among the top end of 
that test is impossible. An acceptable ceiling effect should be less than 15% [56]. Since EQ-
5D only can distinguish between 243 unique health states, the ceiling effect is between 26-
72% [57,58,59,60]. Therefore, EQ-5D lacks the capacity to distinguishing between health 
states that are close to full health. [60]. The SF-36 has in several studies demonstrated a 
non-existing ceiling effect [57,58,60] and is therefore a better instrument for detecting 
differences between healthy subjects. 
A floor effect happens when a high proportion of the patients receive the lowest scores 
when performing a test. Several studies have demonstrated that there are no floor effect for 
EQ-5D [57,60,61]. In the SF-36, the domains Role Physical and Role Emotional has in 
some studies demonstrated a marked floor effect [62,63]. 
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Hip specific questionnaires in the studies 
There are numerous different reliable and validated hip-specific questionnaires to estimate 
hip function in patients having a hip disorder such as Hip Osteoarthritis Outcome Score 
(HOOS) as well as Harris Hip Score (HHS) [64,65]. Both questionnaires have been used in 
studies with elderly patients with a FNF [66,67] but rarely on younger patients. 
 
Hip Disability and Osteoarthritis Outcome Score                                                         
HOOS is a responsive and validated disease-specific questionnaire for the hip [64]. HOOS 
is an instrument for analyzing hip disability with or without osteoarthritis. It has five joint-
specific subscales: pain, symptoms, ADL, function in sports and recreation and joint-related 
quality of life [68]. HOOS is used to measure pain and changes over time in patients having 
a hip disability [64]. Each subscale consists of questions that are graded 0-4 (0 means no 
problems and 4 extreme problems). Each subscale is scored from 0- 100 where 0 indicates 
worse outcome [68]. Each dimension of the HOOS is scored independently. When 
answering the questions, the patients are asked to take the last week into consideration. The 
test-retest reproducibility is high for HOOS (ICC >0.78) [68]. 
 
Harris Hip Score                                                                         
HHS is an instrument that is validated and responsive and evaluates function, pain, 
deformity of the hip and range of motion [65,69]. It has a scale of 100 points in which no 
deformities of the femoral head gives 4 points and no loss of range of motions gives 5 
points. Pain constitute 44 points in which no pain corresponds to a value of 44 and pain that 
is severe corresponds to a value of 0. Function includes evaluation of daily activities and 
walking ability and has a maximum level of 43 points. A total value of less than 70 points 
is categorized as poor, 70-80 good and a value above 80 is considered excellent [65]. 
 
Mental assessment in the study                     
The Short Portable Mental Status Questionnaire (SPMSQ) is a screening instrument for 
cognitive function which is easy to use by healthcare workers. It is composed of 10 
questions and ≥3 errors indicates cognitive impairment [70]. 
 
Mortality 
Few studies have investigated mortality among younger patients having a FNF and these 
were register studies, including several kinds of fractures involving the hip and 
investigating only a few mortality predictors [71,72]. A British cohort study of 300 women 
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younger than 65 years with a hip fracture showed a 46 times higher mortality in these 
patients compared to background mortality [73]. A population-based cohort study of 
154000 hip fracture patients in Denmark showed an excess mortality in younger patients 
with diabetes mellitus [72]. Leu et al reported in a population-based cohort study of 4500 
patients 20-40 years old with a hip fracture that factors associated with increased mortality 
were male gender, treatment with a hemiarthroplasty and a trochanteric fracture [71]. 
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3 RATIONALE 
 
FNF are uncommon in patients younger than 70 years of age and few studies have 
investigated how the hip function, HRQoL and mortality are affected in these relatively 
young patients. Studies with a long-term follow-up are mainly retrospective, registry based, 
and mostly evaluating older patients with a hip fracture. The outcome in older population 
with a FNF fracture might not be applicable on younger patients despite having the same 
type of fracture. 
Retrospective and registry-based studies are limited since there is a lack of ability to detect 
key variables missing from the collected data as well as being prone to selection bias. 
Further, the few studies on younger patients with a hip fracture have not focused on 
HRQoL and self-assessed function but on surgical failures. No study has looked into factors 
associated with surgical failure in younger patients with a FNF treated with CRIF. 
Few studies have investigated mortality in younger patients having a FNF. These studies 
are register-based, included all kind of hip fractures and examined few predictors of 
mortality. 
There is an increased usage of generic instruments for analyzing the HRQoL in the clinical 
settings but the instruments must be validated not only for the specific disease but also for 
the specific group of patients that are intended to be examined. EQ-5D and SF-36 has not 
been validated for younger patients with a FNF fracture nor the responsiveness to detect 
clinical important differences.  
 
The aim of the thesis was to investigate how the hip function and HRQoL were affected in 
the long term after a FNF in patients younger than 70 years treated with CRIF. The thesis 
was also examining if there were factors associated with a major re-operation with a hip 
arthroplasty within two years and factors associated with mortality within 10 years after the 
fracture. Another aim was to determine the responsiveness of EQ-5D and SF 36.  
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4 AIM OF THE THESIS 
 
To evaluate fracture healing complications, re-operations, hip function and 
HRQoL two years after a FNF treated with CRIF in patients 20–69 years of age 
(Study I). 
 
 
To identify which factors that are associated with a major re-operation caused by 
healing complications in patients younger than 70 years having a displaced FNF 
and were treated with CRIF (Study II). 
 
 
To evaluate function of the hip, HRQoL and predictors of mortality 10 years after 
sustaining a FNF treated with CRIF in patients 20-69 years at the time of fracture 
(Study III). 
 
 
To evaluate if EQ-5D and SF-36 are responsive in patients younger than 70 years 
having a FNF treated with CRIF (Study IV). 
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5 PATIENTS 
 
 
ETHICS 
The studies were conducted in accordance with the principles of the Helsinki Declaration 
[74]. All protocols used were approved by the local Ethics Committee (Dnr. 2001-427, Dnr. 
2013-602-32). The study was reporting according to the STROBE checklist [75]. During 
the recruitment the patients were given verbal and written information regarding the study 
and the right to withdraw their consent at any time and for any reason. To protect the 
identity of the included patients, the collected data were linked to each patient through an 
unidentifiable code. The key for opening the patient identity was held separately and 
protected from the collected data. All results were presented on an aggregate-level.            
The follow-up included integrity questions regarding alcohol consumption as well as 
HRQoL but this was not an interventional study and the reply did not affect any treatment. 
A low-dose radiation of an X-ray of the hip joint before and after surgery is regularly 
performed on all patients with a hip fracture. The included patients received an additional 
four X-rays of the hip in a period of 10 years in order to detect fracture healing 
complications. Early detection of healing complication such as NU lead to an early 
intervention and patients with a low BMD were referred to their family physician for 
follow-up and treatment. This may have been unethical toward the excluded patients in 
which the majority probably did not have any follow-up. 
Patients that did not respond to a letter sent to them at 10-year follow-up were phoned by 
the authors included in paper III. This might have caused a sensation of forced participating 
in the 10-year follow-up as well as bringing up memories from the past that were not 
pleasant. However, the authors emphasized during the conversation that participation was 
voluntarily and explained how the study was being conducted and how handling of personal 
data was performed.    
Previous research in this field is lacking and the total benefits for this group outweighs the 
risks participating in these studies. 
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STUDY I  
                                                             
Patients and inclusion criteria 
A total of 182 patients having an age span of 20-69 years (median 59 years, 53% women) 
were consecutively recruited in a prospective multicenter study at four university hospitals 
in Stockholm, Sweden during a 3.5 year-period. All had a FNF either displaced or non-
displaced fracture and all were treated with CRIF by two cannulated screws (Olmed®).  
The inclusion criteria were independent living and able to walk before fracture. Those with 
reduced cognitive function according to Short Portable Mental Status Questionnaire 
(SPMSQ <3) [70] or with a mental disorder were not included. Patients having risk factors 
for a secondary osteoporosis such as chronic renal failure or hyperparathyroidism and a 
simultaneous fracture of a lower extremity were also excluded. Patients with a history of 
pathology in the fractured hip or fractures that were sustained longer than 48 hours before 
admission were also excluded.  
Follow-up                     
The included patients had a follow-up at 4, 12 and 24 months. At 24-months follow-up a 
total of 170 patients were available, 5 missing and 7 patients were deceased (Figure 4). 
 
STUDY II 
 
Patients and inclusion criteria                       
A subgroup of 128 patients from Study I having a displaced FNF and with a median age of 
58 years (range 20-69, 49% men) were included. The criteria of inclusion and exclusion 
were the same as for the Study I. 
 
Follow-up                                                       
The included patients had a follow-up at 4, 12 and 24 months. At 24-months follow-up a 
total of 120 patients were available, 4 missing and 4 patients were deceased (Figure 4). 
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STUDY III 
 
Patients and inclusion criteria                                                                                             
This was a 10-year follow-up of the same cohort as in Study I in which 88 patients   
participated having an age range of 34-80 years and a mean age of 66 years (44% men).  
 
Follow-up                                           
At 10-year follow-up, 55 patients were deceased, 35 patients declined participation and four 
patients were deregistered from public record. For mortality analysis, 178 patients were 
available (Figure 4).  
 
 
STUDY IV 
Patients and inclusion criteria                                                        
All 182 patients from Study I were included with the same inclusion and exclusion criteria 
as for the Study I. 
Follow-up                                                 
The included patients had a follow-up at 4, 12 and 24 months. At 24-months follow-up a 
total of 170 patients were available, 5 missing and 7 patients were deceased (Figure 4). 
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Figure 4. Flow chart of all included patients, missing and deceased at each follow-up. 
 
 
 
 
 
 
 
Patients included at time 
of fracture N=182 
 
Available at 4 months N = 178 
Missing N=4 
Deceased N=0 
 
Available at 12 months N = 174 
Missing N=7 
Deceased N=1 
 
Available at 10 years N = 88 
Missing N=39 
Deceased N=55 
 
Available at 24 months N = 170 
Missing N=5 
Deceased N=7 
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6 METHODS 
 
 
STUDY I 
                                                                                                                                                      
Closed fracture reduction was performed with the help of an image intensifier and the 
fracture was fixated with two parallel screws (Olmed®) and the operations were performed 
by both consultants and residents. 
 
Recorded variables                                                                                                                   
At the time of inclusion, recorded variables were: gender, age, pre-fracture living condition, 
trauma mechanism, alcohol consumption assessed by Alcohol Use Disorder Identification 
Test (AUDIT) [39], and current smoking.  The physical health of the patients was assessed 
by the American Society of Anesthesiologists (ASA) score and was done by an 
anesthesiologist [76]. The ASA score is a subjective assessment of the overall health of the 
patient and is based on six classes (ASA 1−6) [76]. 
All other assessments were done by research nurses except for the ASA score, fracture 
classifications and fracture healing complications.  
 
All patients underwent an X-ray before and after surgery and the FNF was classified 
according to Garden classification, [5]. All X-rays were assessed by three orthopedic 
surgeons in consensus. The fracture reduction according to the postoperative X-ray was 
assessed in regards to displacement, Garden angle and posterior angulation (Figure 5).  A 
good reduction was a displacement ≤ 2 mm, Garden angle 160-175˚ and a dorsal angulation 
< 10˚. A fair reduction was a displacement 2-5 mm, Garden angle 160-175˚ and a dorsal 
angulation < 20˚. A poor reduction was a displacement > 5 mm, Garden angle < 160˚ or > 
175˚ and a dorsal angulation >20˚ [23]. The positioning of the screws was classified as 
good or not good (Figure 5). An X-ray of the operated hip was taken at each follow-up and 
signs of healing complication such as AVN or NU was recorded. 
 
The hip function was examined by HHS [65]. The EQ-5D and SF-36 were used to rate the 
HRQoL [41,42]. Pre-fracture scores of EQ-5D and SF-36, were acquired by asking the 
patients to estimate their quality of life one week before the fracture. At 4,12 and 24-month 
follow-up HHS, SF-36 and EQ-5D were recorded. The change score of SF-36 (between 
pre-fracture level and 24-months follow-up) was compared to MID in order to estimate if 
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the changes were of any clinical importance. According to study IV, the MID for SF-36 
was 8.2. Re-operations were recorded as minor if the screws were extracted and major if the 
patient had a THR. Deep wound infections that required a re-operation with screw-
extraction and a Girdlestone procedure was recorded.   
The living situation was registered as independent or institutionalized. The walking ability 
including using walking aids were registered as ability of walking outside, solely walking 
indoors or inability to walk.  
Three types of mechanism of trauma were recorded. A fall at the same level was considered 
a low-energy trauma, a sport injury mainly by cycling and high-energy trauma from a road 
traffic injury or falling from a height.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. A post-operative X-ray of the pelvis demonstrating a good position of the 
screws after treatment of a FNF with CRIF. The distal screw should be introduced at 
the same region as trochanter minor (A) and run just above the inferior calcar (B). The 
two screws should be 2 cm apart and run parallel (C). The tips of the screws must not 
get closer than 0,5 cm to subchondral bone. (D). Both screws must also run parallel on 
the lateral projection. Their position should be on the posterior third or central on the 
femoral neck and head (E). The Garden angle is the angle between the femoral shaft (F) 
and medial trabeculae in the femoral neck (G). A good reduction is a displacement less 
than 2mm (H), a Garden angle between 160-175° and posterior head angulation of less 
than 10°. (I).  
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STUDY II 
 
Recorded variables                                                                                                            
Gender, age, ASA score [76], Alcohol consumption according to AUDIT [39], BMD, 
smokers, mechanism of injury, fracture reduction and position of the screws. BMD of the 
contralateral hip was examined by DXA within three weeks after sustaining the fracture. 
The BMD from the lumbar spine was used when previous surgery had been performed in 
the contralateral hip. The time intervals for the follow-ups were 4, 12 and 24 months.                 
An X-ray of the operated hip was taken at each follow-up and signs of AVN or NU were 
assessed by three orthopedic surgeons in consensus. Re-operations were recorded as minor 
re-operation if the screws were extracted and major re-operation if the patient had a THR.   
STUDY III 
 
Recorded variables                                                                                                                 
The self-administered questionnaire EQ-5D and HOOS were sent to the patients and the 
results were recorded. All patients included in Study I and not participating in study III had 
their data extracted from the Swedish population registry that revealed any patients who 
were deceased and their date of death was then recorded. Baseline data used for regression 
analysis of predictors of mortality were gender, age, alcoholism, fracture type (displaced or 
non-displaced), co-morbidity, smoking, BMI and osteoporosis (T-score ≤ -2.5 SD in 
subjects >50 years or Z-score < -2 SD in subjects 20-49 years). 
STUDY IV 
 
Recorded variables                                                                                                                  
Both internal and external responsiveness of SF-36, EQ-5D and HHS were evaluated at 
each follow-up. A self-related health (SRH) question was asked at each follow-up where 
the patients had to decide one out of five options describing their state of health; poor, fair, 
good, very good or excellent. The internal responsiveness of EQ-5D and SF-36 were 
estimated by calculating the change score, SES and SRM at each follow-up. The external 
responsiveness was assessed by producing an EC using the SRH question. Patients that 
changed their SRH between any follow-up were classified according to following: 
improved or not, deteriorated or not. A dichotomized ECs was created from these groups 
suitable for ROC analysis and AUC calculations. The external responsiveness was also 
analyzed by calculating correlations between HHS, EQ-5D and SF-36. 
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7 STATISTICS 
 
When performing statistical calculations in study I, II and IV the SPSS version 22 and in 
Study III SPSS version 26 for Windows (IBM) were used. Statistically significance was 
considered when the p-value was less than 0.05 in all analyses. Mean, range, SD, median 
and percentage were used for descriptive statistics. 
 
Study I 
When testing for normally distributed independent variables, the Student’s t test was used. 
Differences in contingency tables were analyzed by Pearson’s chi-square test. 
 
Study II 
A logistic regression analysis was calculated when testing for variables associated with a 
major re-operation. The tested variables were; gender, age (20–49 or 50–69 years), AUDIT 
(low or high in women, and low or high in men), ASA (I-II or III-IV), mechanism of injury 
(low or high energy), fracture reduction (poor-fair or good), smokers or non- smokers, 
position of the screws (good or not good), fracture reduction (poor-fair or good), and BMD 
(normal or osteopenia-osteoporosis). A calculation of unadjusted and adjusted odds ratio 
were performed.  
 
Study III                                            
Differences in contingency tables were analyzed by Pearson’s chi-square test. When testing 
the differences in mean in normally distributed continuous variables the Student t-test and 
paired-sample t-test were used. Analysis of variance (ANOVA) test was calculated when 
analyzing the differences of EQ-5D between the groups according to age. In order to 
identify factors associated with a 10-year mortality, univariate and multiple regression 
calculations were performed. Patients still alive at 10-year follow-up were compared to 
deceased patients. The independent variables analyzed for mortality were: re-operation 
within two years after the fracture yes or no, gender, ASA 1-2 or 3-5, BMI normal (18.5-
24.99) or not, age at time of fracture, non-displaced or displaced FNF, AUDIT low or high, 
diabetes mellitus yes or no, ongoing smoking, osteoporosis yes or no. The confidence 
interval and crude odds ratio were calculated. Cumulative survival was analyzed by a 
Kaplan-Meier curve 
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Study IV                          
The change score was calculated by paired samples t-test. A ROC curve and AUC were 
calculated in order to illustrate the sensitivity and specificity of HHS, EQ-5D and SF-36 to 
predict the EC. A Spearman’s rank correlation coefficient was used when analyzing the 
correlation between scores and changes in scores of HHS, EQ-5D and SF-36. 
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8 RESULTS 
 
 
Study I 
Data of 170 patients were available at 24-month follow-up, five patients were not able to 
attend and seven patients were deceased. A total of 120 patients had a displaced FNF and 
50 patients had a non-displaced FNF. Table 1 illustrates the baseline data of all included 
patients. Figure 6 illustrates the numbers of NU, AVN, deep wound infections, nearby 
fractures and re-operations. A total of 23% (n=27) of the patients with a displaced FNF 
developed NU and 15% (n=18) AVN.  All patients with NU and less than half of patients 
with AVN (n=7) underwent a major re-operation.  In patients who had a non-displaced 
FNF, no one developed NU but 12% (n=6) developed AVN in which later four patients had 
a major re-operation.  
The overall re-operation rate was 41 % in which screw extraction (30%, n=30) and THR 
(23%, n=40) were the two most common surgical procedures. Four patients had a deep 
wound infection after the primary surgery and had a re-operation with a Girdlestone 
resection arthroplasty. A later re-operation with a THR was performed in two of these 
patients. A single patient had a re-operation with CRIF due to a nearby fracture.  
 
The fracture reduction was considered good in 80% (n =101) of the patients with a 
displaced FNF and fair or poor in 20% (n = 26). Positions of the screws in patients with 
displaced FNF were good in 76% (n= 97) and a position that was fair or poor in 24% (n = 
30) compared to patients with a non-displaced FNF in which 85% (n = 46) were good and 
15% fair/poor (n = 8).  
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           Table 1.  Baseline data for patients (n=182) according to type of fracture. Variables are  
            expressed in N (%) besides age and BMI that are expressed in mean +/- SD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           AUDIT: Alcohol Use Disorders Identification Test. ASA: American Society of Anesthesiologists 
           classification. BMI: Body Mass Index, aMissing=4, bMissing=5, *Student’s t-test, §Pearson’s chi-square   
           test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. All included patients (n=182) divided by fracture type with a summary of the numbers of NU, 
AVN, deep wound infection, nearby fracture and re-operations. 
 
   
                                      All patients        Non-displaced                 Displaced                     p-value 
                                      N=182               N=54                                N=128 
 
Age mean ± SD            57±8                  57±8                                 58±9                                   0.39*                    
Gender n (%) 
Women                          97 (53)               35 (65)                            62 (48)                              0.043§             
Men                               85 (47)               19 (35)                            66 (52) 
 
Alcohol AUDIT a n (%) 
Low                              137 (77)               46 (87)                            91 (73)                             0.043§  
High                               41 (23)                 7 (13)                            34 (27) 
 
ASA score b n (%) 
1                                     67 (37)                22 (41)                           45 (35)                               0.66§ 
2                                     81 (44)                25 (46)                           56 (44) 
3                                     30 (17)                  6 (11)                           24 (19) 
4                                       4 (2)                    1 (2)                               3 (2) 
 
Smoking                         72 (40)                20 (37)                          52 (41)                              0.651§ 
 
Trauma mechanism 
Low-energy                   137 (75)               39 (72)                          98 (77)                                0.56§  
High-energy trauma        14 (8)                   6 (11)                            8 (6) 
Sport injury                     31 (17)                 9 (17)                           22 (17) 
 
BMI mean ± SD              24±4                    23±3                             25±4                                0.008*  
Included 
n = 182 
 
Non-displaced 
n = 54 
 
Displaced 
n = 128 
 
Available at 24 months (n = 50) 
missing n=1, deceased n=3 
-NU n=0  
-AVN n = 6, re-op n = 4  
-Deep infection n = 0 
Extraction of screws n=12  
Available at 24 months (n = 120) 
missing n =4, deceased n = 4 
-NU  n = 27, re-op. n = 27  
-AVN n = 18, re-op. n = 7 
-Deep infection n = 4, re-op. n = 4 
-Nearby fracture n = 1, re-op. n = 1  
Extraction of screws n = 18  
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Functional outcome                
Patients with a non-displaced FNF had significant better hip function according to HHS at 
4- and 12-month follow-ups compared to individuals with a displaced FNF; however, the 
differences levelled out at 24-month follow-up (Table 2).   
Table 2. Harris Hip Score at 4, 12 and 24-month follow-up. 
 
 
Patients having a displaced FNF and no re-operation had a good or excellent functional 
outcome in 80 % of the cases at 24-month follow-up compared to 57% in patients that 
underwent a major re-operation (p=0.001). 
Health-related quality of life                   
The score of EQ-5D was reduced from pre-fracture score and had the lowest value at 4-
month follow-up (p<0.001) and did not fully recover at 24-month follow-up (p<0.001). 
Patients with a non-displaced FNF scored higher than patients with a displaced FNF at all 
follow-ups but there was no statistically significant difference at 24-month follow-up 
(Figure 7). 
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         Figure 7. EQ-5D Index score at pre-fracture and at each follow-up. 
 
 
         Figure 8. EQ-5D Index score for patients with a displaced FNF with or without a major re-operation. 
 
Patients with a displaced FNF and a major re-operation with a THR scored significantly 
lower at each follow-up except at 24-month follow-up (Figure 8). 
The mean SF-36 total score in all patients were at the lowest at 4-month follow-up. The 
recovery for the mental score was greater than physical score for all patients regardless of 
0
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0,6
0,8
1
pre-fracture 4 months 12 months 24 months
EQ-5D for all patients
Non-displaced Displaced
p=0.08 p=0.02 p=0.02 p=0.07
0
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0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1
pre-fracture 4 months 12 months 24 months
EQ-5D in patients with displaced FNF
No re-operation Major re-operation
p=0.01 p=0.01 p<0.01 p=0.09
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the type of FNF (Figure 9). In patients with non-displaced FNF the changes from pre-
fracture to 24-month follow-up was significant lower for PF, BP, GH, VT and MH. Patients 
with displaced FNF scored significant lower in each sub-scale between pre-fracture level 
and 24-months follow-up (Table 3). Patients with displaced FNF and a major re-operation 
had a significant lower values both before fracture and at 24-month follow-up at all sub-
scales compared to patients with a displaced FNF and without a major re-operation. 
 
 
  
Figure 9. SF-36 index score at pre-fracture and at each follow-up for non-displaced and displaced       
FNF. The index scores are divided into mental and physical subscales. 
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    Table 3. The SF-36 subscales before fracture and at 24-month follow up and the change score. The values are     
    presented as mean (SD). P-value for differences across the groups using the Pearson chi-square test. 
 
 
 
 
 
 Non-displaced Displaced 
 Displaced fracture with or without a 
major re-operation 
   
 No major re-
operation 
 
 
Major  
re-operations 
Numbers of patients 45 113  79  34 
Physical functioning (PF) 
Before fracture  
24-month 
change score 
p-value 
85 (23) 
71 (31) 
14 (23) 
<0.001 
75 (29) 
58 (31) 
17 (28) 
<0.001 
 
78 (29) 
64 (30) 
14 (22) 
<0.001 
 
68 (31) 
44 (29) 
24 (38) 
0.001 
Role physical (RP) 
Before fracture  
24-month 
change score 
p-value 
83 (34) 
76 (37) 
8 (42) 
0.2 
75 (37) 
57 (44) 
18 (42) 
<0.001 
  
80 (34) 
64 (42) 
16 (40) 
<0.001 
 
62 (43) 
38 (43) 
24 (48) 
0.008 
Bodily Pain (BP) 
Before fracture 
24-month 
change score 
p-value 
87 (25) 
77 (27) 
10 (27) 
0.008 
80 (26) 
65 (32) 
15 (30) 
<0.001 
 
84 (22) 
70 (29) 
14 (24) 
<0.001 
 
72 (31) 
56 (37) 
16 (41) 
0.025 
General Health (GH) 
Before fracture 
24-month 
change score 
p-value 
77 (20) 
71 (24) 
6 (18) 
0.04 
72 (23) 
66 (24) 
6 (21) 
0.001 
 
77 (20) 
70 (23) 
7 (18) 
0.002 
 
62 (27) 
57 (24) 
5 (25) 
0.2 
Vitality (VT) 
Before fracture  
24-month 
change score 
p-value 
76 (24) 
68 (29) 
8 (23) 
0.03 
71 (25) 
62 (29) 
9 26) 
<0.001 
  
76 (21) 
67 (27) 
9 (23) 
0.002 
 
60 (29) 
50 (30) 
10 (31) 
0.09 
Social functioning (SF) 
Before fracture  
24-month 
change score 
p-value 
89 (24) 
86 (23) 
3 (24) 
0.4 
85 (23) 
75 (30) 
11 (27) 
<0.001 
 
90 (18) 
80 (28) 
10 (24) 
0.001 
 
75 (28) 
62 (32) 
13 (31) 
0.023 
Role emotional (RE) 
Before fracture 
24-month 
change score 
p-value 
83 (31) 
74 (42) 
9 (43) 
0.17 
 80 (36) 
65 (44) 
15 (46) 
0.001 
 
87 (29) 
74 (41) 
13 (41) 
0.001 
 
64 (45) 
44 (46) 
20 (57) 
0.06 
Mental health (MH) 
Before fracture 
24-month 
Change score  
P-value 
85 (20) 
79 (24) 
6 (18) 
0.02 
80 (20) 
75 (27) 
5 (24) 
0.001 
 
83 (19) 
80 (24) 
3 (23) 
0.25 
 
73 (23) 
64 (30) 
9 (28) 
0.054 
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Study II 
 
A total of 120 patients were available at 24-month follow-up, four patients were not able to 
attend and four patients were deceased. Mean age was 58 years (20-69 years, 49 % men).  
Table 4 illustrates the baseline data of all included patients. 
 
Table 4. Baseline data for all patients (n=120)  
with a displaced femoral neck fracture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AUDIT: Alcohol Use Disorders Identifications Test. 
ASA: American Society of Anesthesiologists classification. 
a Missing n=2, b missing n=5 
 
The development of AVN was seen in 15% (n=18) of the patients and NU in 23% (n=27). 
Screw extraction was performed in 15% (n=18) of the patients and 28% (n=33) had a major 
re-operation with a THR. The re-operation rate with a THR was 9% (n=2) in patients 
having a normal neck BMD comparing to 31% (n=25) in patients having a low neck BMD 
(p=0.05). Patients with a low risk of alcoholism according to AUDIT had a major re-
operation rate of 22% (n=19) comparing to 44% (n=14) in those with a harmful alcohol 
consumption (p=0.02). Poor fracture reduction was seen in two patients and both had a 
major re-operation.  
 
 
 
 
 
Age, mean 58 
(SD=9) 
N % 
Gender 
Male 
Female 
 
59 (49) 
61 (51) 
Age group 
20-49 years 
50-69 years 
 
 19  (16) 
101 (84) 
Alcohol AUDIT a  
High 
Low 
 
32 (27) 
86 (73) 
ASA score b 
1-2 
3-5 
 
90 (78) 
25 (22) 
Mechanism of injury 
Low-energy trauma 
High-energy/sports trauma 
 
91 (76) 
29 (24) 
Smokers 45 (38) 
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Table 5. Major re-operation due to NU or AVN and logistic regression analysis of all included variables. 
 
  
Re-operation due to NU or AVN 
Yes  n=33          No n=87 
 
  
n (%) 
 
 
n (%) 
 
Unadjusted 
OR (95 % CI) 
 
P-value 
Age group 
 20-49 years  
 50-69 years 
 
2   (11) 
31 (31) 
 
17 (89) 
70 (69) 
 
3.7 (0.80-17.05) 
 
0.09 
ASA score a  
  1-2 
  3-5 
 
23 (26) 
9   (36) 
 
67 (74) 
16 (64) 
 
1.7 (0.64-4.27) 
 
0.29 
Alcohol AUDIT b 
  Low  
  High 
 
19 (22) 
14 (44) 
 
67 (78) 
18 (56) 
 
2.8 (1.17-6.60) 
 
0.02 
Fracture reduction  
  Good 
  Fair/ Poor 
 
23 (24) 
10 (38) 
 
71 (76) 
16 (62) 
 
2.0 (0.78-4.91) 
 
0.15 
Gender  
  Male  
  Female 
 
15 (25) 
18 (30) 
 
44 (75) 
43 (70) 
 
1.2 (0.53-2.68) 
 
0.66 
Mechanism of injury  
  Low energy  
  Sports or high energy 
 
 
29 (32) 
4   (14) 
 
62 (68) 
25 (86) 
 
2.9 (0.91-9.03) 
 
0.07 
BMD femoral neck c 
  Normal  
  Osteopenia or osteoporosis 
 
 
2   (9) 
25 (31) 
 
21 (91) 
55 (69) 
 
4.8  (1.03-21.9) 
 
0.05 
Smoking  
   No  
   Yes 
 
 
17 (23) 
16 (36) 
 
58 (77) 
29 (64) 
 
 
1.9 (0.84-4.33) 
 
0.12 
Position of the screws 
 Good 
 Not good 
 
23 (25) 
10 (36) 
 
69 (75) 
18 (64) 
 
1.7 (0.68-4-18) 
 
0.26 
                      a missing n = 5, b missing n = 2, c missing n = 17 
 
 
The logistic regression analysis showed that a high AUDIT score and osteopenia or 
osteoporosis were significant factors for re-operation (Table 5) as well as in the 
multivariable logistic regression analysis (Table 6).  
Table 6. A multivariable logistic regression analysis of high AUDIT and BMD of the contralateral hip and the 
association with a major re-operation. 
 
  
OR (95 % CI) 
 
P-value 
AUDIT a 
High versus low AUDIT 
   
 
3.2 (1.16-8.76) 
 
0.02 
  BMD b 
Normal versus osteopenia or 
osteoporosis  
5.5 (1.15-26.8) 0.03 
                           a missing n = 2, b missing n = 17  
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Study III 
 
The participants were 88 patients with an average age of 66 years (34-80 years, 44% men). 
A total of 55 patients were dead, four patients deregistered from public records and 35 
patients denied participation. For mortality estimate, data of 178 patients were available.  
 
Hip Disability and Osteoarthritis Outcome Score  
Except for sport/recreation, women scored better than men in all domains but the 
differences were not significant in any domain (Table 7). No significant differences were 
detected comparing patients with displaced and non-displaced FNF (Table 7). Significant 
differences were seen between the younger age group compared to the older age in all 
domains except for symptoms (Table 7).  
  
Table 7. Hip disability and Osteoarthritis Outcome Score (HOOS) 10 years after a FNF. All values are presented 
as mean and standard deviation (SD). 
 
  
Women 
 
Men 
p-value Non- 
Displaced 
Displaced  p-    
value 
Age 
30-69 
    Age 
     ≥70 
P-value 
 N= 48 N=39  N=26 N=61  N=33 N=54  
Pain  85 (19) 82 (23) 0.60 85 (20) 83 (22) 0.62 91(18) 79 (21) 0.01 
Symptom 82 (17) 81 (23) 0.77 83 (21) 81 (19) 0.59 89 (18) 77 (20) 0.07 
ADL  82 (21) 81 (24) 0.90 85 (20) 80 (24) 0.33 92 (17) 75 (23) <0.01 
Sport/ 
Recreation 
65 (33) 68 (33) 0.68 73 (32) 64 (33) 0.26 84 (24) 56 (33) <0.01 
QoL 76 (23) 72 (30) 0.53 79 (24) 72 (27) 0.31 79 (24) 72 (27) 0.03 
ADL= Activities of daily living 
QoL= Quality of life 
 
Health related quality of life 
EQ-5D improved comparing to the 4 (p<0.001), 12 (p=0.001) and 24-month (p=0.006) 
scores (Figure 10). The pre-fracture level of EQ-5D however, was not reached (p<0.001) 
(Fig. 10). There was no statistically significant difference between gender (p=0.587), 
fracture displacement or not (p=0.942), (Figure 10), age groups (p=0.094), (Table 8), and 
mechanism of injury (p=0.385).  
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  Table 8. EQ-5D in different age groups at 10-year follow-up.  
  Values are given as Mean (SD), (p=0.094). 
 
Age group Mean (SD) 
35–64  n=22 0.91 (0.22) 
65–74  n=47 0.81 (0.18) 
75+      n=19 0.79 (0.22) 
Total    n=88 0.83 (0.20) 
  
 
 
    Figure 10. Mean EQ-5D for all patients, split into gender and type of fracture at each follow-up. 
 
 
A non-response bias analysis of the patients (n=35) still alive and not participating in the 
study was performed. These patients had a mean age of 55 years when sustaining their 
fracture in comparison to 56 years for the patients included in the study. There was no 
statistically significant difference in the HRQoL at 24-month follow-up (p=0.122).  
 
Mortality 
The mean age at death date was 70 and 68 years for women and men respectively. A 
Kaplan-Meier curve illustrates the cumulative survival according to gender and a gradual 
reduction of cumulative survival is seen. At 10-year follow-up 70% were still alive and 
30% of the men and 32% of the women were dead (Figure 11).  
 
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1
All patients n=88 Men n=39 Women n=49 Non-displaced n=26 Displaced n=62
EQ-5D
Pre-fracture 4months 12 months 24 months 10 years
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Factors associated with mortality in the univariate regression analysis were ASA score 3-5, 
high age at time of fracture, diabetes mellitus, high AUDIT, osteoporosis and ongoing 
smoking (Table 9). Factors that were still significant in the multi-regression analysis were 
ASA 3-5, osteoporosis, age at time of fracture, and ongoing smoking (Table 10). Within the 
group of deceased patients, 49% had a high AUDIT, 22% diabetes mellitus, and 69% had 
an ongoing smoking at the time of fracture.  
 
Table 9. Characteristics of all patients at inclusion, deceased and alive 10 years after the hip fracture. Data are 
presented as n (%).  
 
 
 
All patients 
 N=178 
Deceased 
 N=55 
Alive 
 N=123 
p-value 
Age at time of fracture mean (SD)   58 (9)  62 (5)   56 (9)   0.01 
BMI mean (SD)   24 (4)  24 (3)   25 (5)   0.23 
   n (%)  n (%)    n (%)  
Gender  
women 
men 
 
  96 (54) 
  82 (46) 
 
 30 (31) 
 25 (30) 
 
  66 (69) 
  57 (70) 
 
  0.91 
Re-operation within two years a    37 (22)  13 (35)   24 (65)   0.25 
ASA b  
1-2  
3-5 
 
139 (80) 
  34 (20) 
 
 30 (28) 
 24 (70) 
 
109 (78) 
  10 (30) 
 
<0.01 
AUDIT c  
High 
 
  41 (24) 
 
 22 (54) 
 
  19 (46) 
 
  0.02 
Non-displaced fracture  
Displaced fracture  
  53 (30) 
125 (70) 
 16 (30) 
 39 (31) 
  37 (70) 
  86 (39) 
  0.89 
Osteoporosis d   49 (32)  20 (41)   29 (59)   0.02 
Diabetes mellitus   19 (11)  12 (63)     7 (37)   0.01 
Smoking   72 (40)  38 (53)   34 (47) <0.01 
a Missing 12, b missing 5, c missing 4, d missing 25. 
 
 
Table 10. Multiple regression analysis (n=144a) of factors at baseline associated with 10-year mortality. Data are 
illustrated as adjusted odds ratio (OR) and 95% confidence interval (CI). 
 
Variable Adjusted  OR CI (95%) 
ASA 1-2 & 3-5 7.26 2.46-21.43 
Age at time of fracture 1.15 1.05-1.26 
Smoking 5.22 1.87-14.57 
Osteoporosis 2.71 1.04-7.05 
                                                          a Missing 34. 
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          Figure 11. A Kaplan-Meier analysis of cumulative survival according to gender in patients with a FNF.  
 
Study IV 
A total of 163 complete questionnaires of EQ-5D and 156 complete questionnaires of SF-
36 from baseline, 4-months, 12 months and 24-months follow-up were available for 
analysis.  
The ceiling effect of EQ-5D was 57% at baseline, 12% at 4 months, 20% at 12 months and 
23% at 24-month follow-up. The ceiling effect of SF-36 were 3% at baseline and 0% at 4 
months, 1% at 12 months and 3% at 24-month follow-up. Either EQ-5D nor SF-36 had any 
floor-effect. The MID was 8.2 for SF-36 and 0.05 for EQ-5D. At all follow-up the change 
scores of SF-36 and EQ-5D were significant larger than MID.  Cohen´s threshold [54] 
revealed that the SES for both SF-36 and EQ-5D were large at 4 months (Table 11). At 12 
and 24 months the SES was moderate to large (Table 11). The change score between HHS 
and SF-36 (0.37, n=147), HHS and EQ-5D (0.44, n=156) and SF-36 and EQ-5D (0.64, 
n=152) had a correlation that was significant positive between 4 and 24 months. The 
correlation between SF-36 and EQ-5D was stronger comparing any of the generic HRQoL 
questionnaires to HHS (Table 12). 
AUC calculations showed that both EQ-5D and SF-36 could predict improvement between 
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4 and 24 months better than the HHS and was significantly larger than 0.5 within 0–4 and 
0–24-month follow-up (Figure 12.). The results indicated that a change in score in either 
SF-36 and EQ-5D that is positive had both a higher specificity and sensitivity compared to 
HHS when predicting an improvement in the EC.  
 
 
Figure 12. ROC curve and AUC values of change in scores in EQ-5D, SF-36 and HHS. The lines represent 
connected dots of sensitivity and specificity of each individual value of change in score. The larger the area 
under the curve is, the better is the chance of predicting the actual state. 
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Table 11. SF-36 and EQ-5D median, mean, change scores and effect sizes at baseline, 4, 12 and 24-month 
follow-up.  
 
 Baseline 4 months 12 Month 24 Months 
SF 36     
Number of patients 175 170 160 156 
Median (range) 87 (13-100) 59 (6-99) 73 (3-100) 76 (2-100) 
Mean (SD) 77 (23) 59 (25) 67 (27) 68 (27) 
Change score a 
(SD)  
x 19 (20) * 13 (22) * 12 (22) * 
SES x 0.83 0.56 0.52 
SRM x 0.95 0.59 0.55 
EQ-5D     
Number of patients 182 173 167 163 
Median (range) 0.97 (0.44-0.97) 0.78 (0.40-0.97) 0.87 (0.40-0.97) 0.88 (0.40-0.97) 
Mean (SD) 0.90 (0.11) 0.79 (0.13) 0.82 (0.14) 0.83 (0.15) 
Change score a 
(SD) 
x 0.12 (0.12) * 0.09 (0.13) * 0.08 (0.13) * 
SES x 1.09 0.82 0.72 
SRM x 1 0.69 0.62 
 
SF-36= Short Form (36) health Survey, EQ-5D= EuroQol 5-Dimension questionnaire, SES=Standardized effect 
size, SRM= Standardized response mean,
a From baseline,
 *
p < 0.05. 
 
   
 
Table 12. Correlation of SF-36 and EQ-5D index scores and HHS total score of all included patients 
(n=number of patients). 
 Baseline 4 Months 12 Months 24 Months 
Correlated Scores     
SF-36 –- EQ-5D 0.80 (n=175)* 0.83 (n=169) * 0.87 (n=159) * 0.84 (n=155) * 
SF-36 –- HHS  0.73 (n=167) * 0.75 (n=155) * 0.74 (n=154) * 
EQ-5D –- HHS  0.75 (n=169) * 0.79 (n=162) * 0.76 (n=160) * 
 
SF-36= Short Form (36) health Survey, EQ-5D= EuroQol 5-Dimension questionnaire, HHS= Harris Hip 
Score, 
*
p < 0.05. 
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9 DISCUSSIONS 
 
 
Study I 
 
Healing complications, HRQoL and hip function were assessed in this paper with a follow-
up of two years.  
Two-thirds of patients having a displaced FNF healed and did not undergo any major re-
operation and the functional outcome was good or excellent in three-quarters after two 
years.  
Of all patients with a non-displaced FNF, none developed NU and 12% AVN. Only four 
patients had a major re-operation due to AVN. Regardless of fracture type, the pre-fracture 
HRQoL was not reached by the patients. 
 
A trend today is to operate patients with a displaced FNF with a THR if the patient is in the 
age range of 60-69 years [1,10,77]. When comparing patients with displaced FNF, age 
groups 50-59 and 60-69 years in our study, the major re-operation rate was 34 and 31 % 
respectively. These results indicate that the chronological age should not determine 
treatment modality.  
All patients with NU were re-operated but only 46% of the patients who developed AVN. 
Similarly, Haidukewych et al. showed that about 50% of patients developing AVN 
developed symptoms and were in need for a re-operation [19]. Jain et al showed that 
development of AVN did not lead to a significantly reduced functional outcome in younger 
patients with a FNF [18]. Our findings suggest that the development of AVN within two 
years after a FNF does not necessary lead to symptoms nor need for a re-operation.  
The incidence of NU in younger patients with a FNF has been reported to vary between 0-
59% [2,7,19,26,78,79]. However, the definition of NU varies in some studies defining NU 
as a re-displacement if it occurs within 4-6 month after the fracture [2,6]. In our paper, NU 
was defined as lack of healing regardless when that occurred and it affected 23% of all 
patients with a displaced FNF which is somewhat higher than other studies that looked into 
younger patients with a FNF [2,7,26]. The reason for our higher values could be that we 
included patients up to 69 years of age, had a long follow-up period and the definition of 
NU differed compared to other studies. 
In our study, the functional outcome according to HHS was significantly better for patients 
with non-displaced FNF at 4 and 12-month follow-up compared to patients with a displaced 
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FNF. However, this difference had disappeared at 24-month follow-up. These findings 
probably reflect that patients who underwent a major re-operation with a THR had a longer 
time for recovery. Few studies have studied functional outcome in younger patients with a 
FNF treated with a CRIF. Haider et al showed in a retrospective study that the majority of 
younger patients with a FNF treated with internal fixation had an excellent function 
according to HHS at 5-year follow-up [80] which is in accordance with our results.  
The EQ-5D in our study showed that regardless of fracture type, the pre-fracture level was 
not reached and the difference from 24-month follow-up was significantly. The MID of 
EQ-5D in our study material was 0.05 shown in study IV and was smaller than the change 
score between pre-fracture level and at 24-month follow-up for both patients with displaced 
and non-displaced FNF. A study by Tidermark et al showed that elderly patients with a 
non-displaced FNF without healing complications regained the pre-fracture level of EQ-5D 
which is in contrast to our study [81]. The reason might be that a slight functional 
impairment in younger patients with a higher functional demand may influence their 
HRQoL to a greater extent than in elderly.  
The change scores of SF-36 had the same pattern as EQ-5D with the lowest values at 4 
months and a recovery at 24 months but not to the pre-fracture level for any subscale.         
The mental scores recovered more than the physical scores for both patients with displaced 
and non-displaced FNF as well as those who had a major re-operation. Zidén et al. reported 
a profound psychological and social impact in elderly with a hip fracture [82]. As far as we 
know this has not been looked at in younger patients with a FNF and one could assume that 
rehabilitation should consider a reduction in mental health after a FNF.             
 
Study II 
Predictors of fracture healing comlications after a FNF were assessed in this paper.        
The results showed that both osteopenia and osteoporosis as well as a harmful alcohol use 
according to AUDIT were factors associated with a major re-operation. The rate of re-
operation in our study was 28% which is similar to other studies in younger patients with a 
FNF [7,83]. There are several studies reporting that the fracture healing is affected by a low 
BMD [30,31,84]. However, other studies did not find any association with a low BMD and 
increased re-operations in patients with a FNF but the mean age was above 80 years 
[29,85]. A DXA scan is the standard method of assessing the BMD but rarely performed 
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pre-operatively since the examination itself requires a thoroughly position of the patient on 
the investigation table which due to pain is not feasible [86]. Erhart et al showed that a CT 
scan with a calibration device performed pre-operatively on the non-fractured hip was 
easily obtained and estimated the BMD as well as a DXA [86]. However, if a CT scan 
could work as a tool for estimating the risk of a re-operation due to osteopenia or 
osteoporosis and thus being an aid to choose the best surgical method needs further 
research. 
Our study showed that individuals with a high alcohol consumption according to AUDIT 
had a significantly higher rate of a major re-operation. A similar finding was seen in 
another study that showed a significant association between alcoholism and fixation failure 
in younger patients with a FNF [6]. The bone metabolism is affected by high alcohol 
consumption and therefore has an impact om the BMD [36,37]. The etiology of alcohol-
associated bone disease is multifactorial [37]. Chronic alcohol abuse causes elevated serum 
parathyroid hormone (PTH) and low serum levels of vitamin D which cause malabsorption 
of calcium [37]. Alcohol also directly suppress the function of osteoblasts [37], increases 
the risk of falling, contributes to malnutrition and causes development of co-morbidities 
[37,38].  
In the sub-analysis of major re-operations in different age-groups in our study, no 
statistically significance was seen and the reason for that could be a low number of patients 
less than 50 years of age or a type II error.  
Female gender was not a risk for a re-operation in our study which is in contrast to another 
study that showed an increased risk in women regardless of age [8]. However, the average 
age in that study was 76 years and BMD was not measured [8] which may explain the 
difference.  
The positions of the screws did not affect the re-operation rate in our study. A prospective 
study with a two-year follow-up by Lindquist et al, showed that a suboptimal position of 
the screws was significantly associated with NU [23]. The analysis of the screw position 
was slightly different, the BMD was not measured, included older patients [23] which all 
may have influenced the results compared to our findings. 
Only two patients in our study had a fracture reduction that was poor and these patients 
underwent a major re-operation indicating that it is of clinical importance to achieve an 
optimal fracture reduction.  
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Smoking was not associated with a major re-operation in our study. However, there is 
overwhelming evidence that smoking has a negative impact on fracture healing 
[87,88,89,90]. Increased rate of non-union has been demonstrated among smokers with an 
open fracture [89]. We cannot tell why smoking did not influence the rate of major re-
operation in our study but surgery with two cannulated screws were a relatively minor 
surgical procedure with little soft tissue trauma.  
 
Study III 
The clinical outcome and HRQoL 10 years after a FNF and factors associated with 
mortality were assessed in this paper. 
 
The results of HOOS at 10-year follow-up showed that the domain sport activities were 
most affected which has also been shown after THR in patients with osteoarthritis with a 
six-months follow-up [69].  
Younger patients reported less hip-related complains compared to patients above 70 years 
in every subscale and the differences were statistically significant. Similar findings were 
demonstrated in a cohort study of normal population in Sweden that included 840 
individuals that were randomly included and had an age-span between 18-84 years [91]. 
But in that study, men scored higher than women in every subscale of HOOS regardless of 
age which were in contrast to our findings [91]. The results in our study implies that a FNF 
affects men to a higher degree according to HOOS but the differences were not statistically 
significant. 
 
The patients did not reach the pre-fracture score of the EQ-5D but continued to improve 
when comparing to the two-year follow-up. However, the results may have been affected 
that the patients were 10 years older [50]. Our results of EQ-5D were equivalent to an index 
population of Sweden that were age- and sex-matched [50] which implies that a FNF may 
have little or no effect on the HRQoL in the long term in patients less than 70 years with a 
FNF.  
Studies that demonstrated a statistically significant reduction of EQ-5D due to a hip fracture 
included older patients, had a shorter follow-up than our study and included all types of 
different hip fractures [47,81]. Tidermark et al. demonstrated in elderly patients an inferior 
outcome of the HRQoL if the FNF was displaced compared to non-displaced FNF [81] 
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which was not seen at our study at 10-years follow-up. Our results were likely affected by 
the very long times span of 10 years.  
 
The mechanism of injury did not affect the HRQoL at 10-year follow-up and the reason 
might be that mainly younger patients in our study had a high energy trauma and did not 
undergo a major re-operation within the two first years.  
 
At 2-year follow-up 8% were dead which are quite low after a FNF fracture. At 10-year 
follow-up, two thirds of the patients were still alive. The deceased patients were more 
compromised with diabetes and unhealthy lifestyles with higher alcohol consumption and 
smoking compared to the patients still alive and to general population data of Sweden 
[92,93,94].   
Osteoporosis was associated with a 10-year mortality in our study which has been 
demonstrated in another cohort study in patients with osteoporosis and younger than 70 
years of age [95]. In contrast to other studies we could not reveal that men had increased 
mortality compared to women [96,97]. Several studies have shown that within a year there 
is a sharp reduction of survival in males with a mortality of up to 25% [98]. The average 
age was about 80 years in these studies which probably explains the difference from our 
findings [96,97,98].  
 
Study IV 
The responsiveness of the HRQoL questionnaires EQ-5D and SF-36 were assessed among 
patients 20-69 years of age with a FNF. Both instruments had large effect sizes at 4 months 
but were decreased at 12 and 24-month follow-ups. The EQ-5D and SF-36 questionnaires 
were more sensitive than the hip-specific instrument in their ability to detect subjective 
improvements of health.  
 
Internal responsiveness 
The internal responsiveness represented by the effect sizes were for both SF-36 and EQ-5D 
large at 4-month follow-up and decreased at 12 and 24-month follow-ups. The MID was 
significant lower than the mean change score at each follow-up indicating a good internal 
responsiveness for both SF-36 and EQ-5D. Other studies have also shown a good internal 
responsiveness of SF-36 and EQ-5D among relatively healthy elderly that sustained a hip 
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fracture [43,44,45,47,99]. However, Frihagen et al demonstrated in their study, small effect 
sizes of EQ-5D in patients sustaining a FNF with a 4 and 12-months follow-up [44]. The 
explanation for the lack of internal responsiveness according to the authors were that 
patients with cognitive impairment had a lower response rate [44].  
Analysis of effect sizes                 
There is a lack of consensus on which effect size to include as well as interpreting the 
results which makes comparison with other studies difficult [53,100,101]. The Cohen’s 
threshold was used in our study when calculating and estimating the SRM and SES effect 
sizes, which is a method mostly used in orthopedic studies when estimating the internal 
responsiveness [102]. To measure recovery, the pre-fracture level is necessary to measure. 
This causes a concern of recall bias which is a systematic error caused by differences in 
completeness or accuracy of the recollections retrieved regarding the experiences from the 
past [103]. Previous studies that included pre-fracture scores of HRQoL in patients with a 
FNF showed equivalent values of Swedish reference population that were age and sex-
matched and therefore recall bias appears to be low [43,45,104]. The internal 
responsiveness was also analyzed over multiple time frames. That allowed us to measure if 
it was possible to detect a change in EQ-5D and SF-36 up to two years after sustaining a 
FNF.  
External responsiveness                       
A weak positive correlation in change scores between HHS and HRQoL questionnaires 
were seen and a strong positive correlation for total scores. Similar findings have been 
shown in other studies in elderly [43,47,99]. The explanation for the moderate to weak 
positive correlation in change scores is that the scores are measuring outcomes that differs 
from each other and only partial address the same aspect of mobility and pain. HHS was 
inferior to both EQ-5D and SF-36 in predicting a subjective improvement in the time-frame 
of 4 to 24 months. EQ-5D had a somewhat smaller AUC than SF-36 in all time frames. 
HHS did not have a predictive value of changes in subjective health since the AUC was 
close to 0.5. 
The choice of external criteria               
Studies in elderly that sustained a hip fracture have illustrated an external responsiveness in 
both EQ-5D and SF-36 that was adequate, although the evaluation methods have varied 
[43,44,45,99]. In one of the studies, the external criterion used pain, range of motion and 
walking ability when calculating the correlation to the HRQoL [99]. A dichotomized ECs 
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was used in other studies that was based upon walking ability, displacement of the fracture, 
pain, complications or death [43,44,45,47]. In these studies, the EC was a measure of 
clinical outcome but the patient´s subjective state of health was not necessarily address. 
Therefore, in our study we constructed an EC based upon the change in the subjective 
deterioration or improvement in health using the SRH-question. Using a change in SRH as 
the EC is not an obvious choice nor a “gold standard” but we believe it is superior since it 
can be used regardless of state of medical condition, being generic and there is no need for 
constructing an EC specifically for each medical condition. 
The Swedish experience-based value sets for EQ-5D                  
The value set developed by Burström et al and based on a Swedish population was used in 
this paper [50]. An argument favoring the Swedish experience-based value set is that 
subjects with their own experience from the health states are often considerably better 
informed about their condition compared with the value health states that is based merely 
on a description. The description method does not estimate adaptations to changes in health 
and therefore we believe it is inferior. However, using the Swedish value sets, it makes it 
more difficult to compare to older studies. 
EQ-5D versus SF-36                     
The ceiling effect of EQ-5D was larger than SF-36. A review study of EQ-5D showed that 
the ceiling effect was above 15% in half of the study groups but did not have any floor 
effect [105]. The ceiling effect at baseline of the EQ-5D were not an issue in this study and 
a fracture is expected to worsen the HRQoL. Incomplete SF-36 questionnaires were twice 
that of EQ-5D questionnaires probably because SF-36 takes more time to complete which 
has been demonstrated in other studies [42,50]. A SF-36 global score was constructed in 
our study in order to compare to EQ-5D, which has been done in a previous study 
evaluating responsiveness in orthopedic research [45]. A single score is preferred in our 
opinion when estimating HRQoL in a clinical setting. EQ-5D is easy to administer and 
calculate in comparison to the SF-36 which appears not adding additional information. 
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10 STRENGTH AND WEAKNESSES 
 
The strengths of the papers were that high quality data collected by research nurses, low 
drop out, prospective multicenter design and a long follow-up which included radiological, 
clinical and functional outcome. Limitations were the wide age range of the included 
patients and the exclusion of patients that were compromised with renal failure, multiple 
fractures, hyperparathyroidism, inability to walk, staying in institution and having cognitive 
impairment. Therefore our findings may not be representative for all patients. Fracture 
healing complication may also have been affected by the nutritional state of the patients but 
no blood samples were analyzed for malnutrition in our study. 
Another weakness is the wide CI in paper II due to a small sample size.  
 
The included patients in paper III may not be representative for all patients initially 
included since 10 years had passed. However, a non-response bias analysis of non-included 
patients showed a similar age and EQ-5D score as the included patients at 24-months 
follow-up indicating that our results are representative. Another limitation in study III is the 
relatively few patients in each age- and sex subgroup and therefore a risk of type II error 
when comparing our results with large population-based cohort studies in Sweden. 
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11 IMPLICATIONS AND FUTURE DIRECTIONS 
 
 
Our findings suggest that CRIF should be used in the majority of the patients younger than 
70 years with a FNF regardless of fracture displacement since the functional outcome was 
good or excellent and a major re-operation rate was less than 30%. Only age as a guide for 
surgical method may not be rational and risk factors for a major re-operation should be 
taken into account. 
 
The HRQoL and hip function in the surviving patients do recover over time and 10 years 
later the patients reach an equivalent value as the general population. A reduction in mental 
health was seen in these patients during the first two years and should be considered during 
rehabilitation. 
 
A third of the patients died within 10 years after the fracture but these patients were 
compromised with co-morbidities and smoking. Male gender is not a risk factor for 10-year 
mortality, in contrast to what has been shown in elderly patients with a FNF. 
 
Future studies should preferable have a control group without a hip fracture or hip disorder 
which would allow a more accurate analysis of the impact of a FNF on HRQoL and hip 
function. The debate on whether to operate a patient with a displaced FNF with CRIF or a 
THR are aimed at patients between 60-70 years of age. Future studies should specifically 
investigate patients in this range of age since comorbidities and mechanism of trauma 
differs in different age categories.  
Osteoporosis increases the risk of a major re-operation within 2 years and mortality within 
10 years. Studies analyzing the impact of osteoporosis on patients 60-70 years of age 
treated with either CRIF or THR after a displaced FNF would be of interest as well as pre-
fracture modalities of accessing BMD.  
Alcoholism is another risk factor for a major-re-operation in patients with a displaced FNF 
treated with CRIF. Alcohol consumption should always be a part of medical history and is 
relatively easy to obtain before surgery.  
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12 CONCLUSION 
 
 
Two-third of the patients having a displaced FNF did heal after the CRIF and the functional 
outcome was good or excellent in three-quarters. The patients did not recover to the pre-
fracture level. 
 
HRQoL continued to improve between 4, 12 and 24 months as well as between 24 months 
and 10 years.   
 
A low BMD and alcoholism were associated with a major re-operation within 2 years after 
the fracture. 
 
10 years after a FNF, the hip function and HRQoL were in accordance to sex and age-
matched Swedish reference population. 
 
A third of the patients had deceased within 10-year despite being relatively young and these 
patients were more compromised by co-morbidities and smoking. 
Age, co-morbidity, smoking and osteoporosis were associated with 10-years mortality. 
 
Both SF-36 and EQ-5D had a good internal and external responsiveness for patients less 
than 70 years with a FNF treated with CRIF. 
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14 SUMMERING PÅ SVENSKA 
 
Ett brott på lårbenshalsen kan ha långtgående konsekvenser på patientens livskvalitet, 
mortalitet och funktion speciellt hos patienter yngre än 70 år. Långsiktiga konsekvenser är 
okända då de flesta studier har en kort uppföljningstid. Denna avhandling består av fyra 
delarbeten som studerat en kohort av patienter 20-69 år gamla med ett brott på 
lårbenshalsen och behandlade med sluten reponering och internfixation med Olmed 
skruvar.  
Delarbete I: Syftet med delarbete I var att undersöka hälsorelaterad livskvalitet, 
höftfunktion och kirurgiska komplikationer under de 2 första åren efter lårbenshalsfraktur. 
Patienterna var mellan 20-69 år och samtliga frakturer hade behandlats med sluten 
reposition och skruvfixation. Detta var en prospektiv multicenter studie med 4,12 och 24 
månadersuppföljning. 182 patienter inkluderades och egenskattad livskvalitet (HRQoL) 
registrerades med utvärderingsinstrumenten EQ-5D och SF-36. Höftfunktionen mättes med 
Harris Hip Score (HHS). Röntgen av höften togs vid alla uppföljningar och uppkomst av 
pseudartros (ej läkt faktur) eller avaskulär nekros (AVN) av ledkulan registrerades samt om 
och typ av reoperation.  
HRQoL skattades lägst vid 4 månader, ökade vid 12 och 24 månaders uppföljning men 
nådde inte prefraktur nivå. HHS var som lägst vid 4 månader och vid 24 månader var 
höftfunktionen god eller mycket god hos 73% av patienterna. Pseudartros utvecklades hos 
23% och AVN registrerades hos 15%. Totalt genomgick 23% en reoperation med 
höftplastik inom de 24 månaderna. 
HRQoL förbättras gradvis men når inte samma nivå som före frakturen. Majoriteten återfår 
en god eller mycket god höftfunktion och en fjärdedel reopereras med höftprotes. 
 
Delarbete II: Syftet med delarbete II var att undersöka om det fanns faktorer vid 
frakturtillfället associerade med en senare reoperation med höftprotes p.g.a. 
läkningsstörning eller AVN efter en felställd lårbenshalsfraktur. Patienterna behandlades 
initialt med sluten reposition och skruvfixation och var mellan 20-69 år.  
128 patienter inkluderades och under vårdtillfället registrerades ASA-grad (American 
Society of Anesthesiologists Physical Status), alkoholvanor (AUDIT), komorbiditet och 
rökning. Bentäthet (BMD) av höften mättes med DXA (dual-energy x-ray absortiometry) i 
nära anslutning i tid till frakturtillfället. Röntgenundersökning av frakturerade höften 
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utfördes postoperativt samt vid 4, 12 och 24 månader. Läkningsstörningar, tecken på AVN 
samt om reoperation utförts registrerades.  
Samband mellan ovannämnda variabler och reoperation med en höftplastik under de första 
2 åren efter höftfrakturen beräknades med en univariatanalys. En logistisk regression av de 
signifikanta variablerna beräknades och resultatet visade att ett lågt BMD i höften och hög 
alkoholkonsumtion hade en association med reoperation inom 24 månader. 
 
Delarbete III: Syftet med delarbete III var att undersöka egenskattad livskvalitet (HRQoL) 
och höftfunktion 10 år efter lårbenshalsfraktur hos patienter mellan 20-69 år. Ett annat syfte 
var att identifiera faktorer associerade med 10 års mortalitet.  
88 patienter kunde inkluderas i uppföljningen och HRQoL mättes med EQ-5D och 
höftfunktionen med Hip dysfunction and Osteoarthritis Outcome Score (HOOS).  
En regressionsanalys av mortalitet utfördes med reoperation inom två år, kön, BMI, ASA 
klass, åldersgrupp 20-49 och 50-69 år, etylism, felställda och icke felställda frakturer, 
rökning, diabetes mellitus och bentäthet (BMD). Signifikanta vid univariatanalysen var 
ASA 3-5, hög ålder, etylism, diabetes, rökning och osteoporos. Dessa beräknades sedan i en 
logistisk regressionsanalys och resultatet visade att ASA 3-5, hög ålder, rökning och 
osteoporos hade ett signifikant samband med 10 års mortalitet. 55 av totalt 178 patienter 
hade avlidit under de första 10 åren efter höftfrakturen. Mortaliteten var 30% hos kvinnor 
och 32% hos männen.  
HRQoL fortsatte förbättras men ej statistiskt signifikant jämfört med tidigare uppmätt 24-
månaders nivå (delarbete I) men nådde ej prefraktur nivå. Ingen signifikant skillnad av 
HRQoL sågs mellan könen, åldersgrupperna, efter ett låg- eller högenergitrauma eller 
mellan felställda respektive icke felställda frakturer. Vid jämförelse av ålder- och 
könsmatchad EQ-5D värden i Sverige sågs ingen skillnad. HOOS visade ingen signifikant 
skillnad mellan kön eller typ av fraktur. 
Delarbete IV: Målet med delarbete IV var att utröna responsivitet hos de hälsorelaterade 
livskvalitetsenkäterna och generiska instrumenten EQ-5D och SF-36 då de används hos 
patienter med lårbenshalsfraktur och en ålder < 70. 182 patienter inkluderades och följdes 
upp vid 4, 12 och 24 månader efter frakturtillfället.  EQ-5D samt SF-36 mättes vid varje 
uppföljning. Smärta och höftfunktion skattades med Harris Hip Score (HHS) vid alla 
uppföljningar. Responsiviteten hos EQ-5D och SF-36 utvärderades genom beräkning av två 
effektmått; standardiserad effekt storlek och standardiserad skillnaden mellan medelvärden 
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av EQ-5D och SF-36 samt hur resultatet korrelerade med höftfunktion mätt med HHS och 
subjektivt hälsotillstånd.  
EQ-5D och SF-36s sensitivitet/specificitet bedömdes med ”receiver operating characteristic 
curve” (ROC-kurva) och area under ROC-kurvan och utfallen jämfördes med resultatet av 
HHS och subjektivt skattad hälsa. Studien visade att EQ-5D och SF-36 har en hög intern 
och extern responsivitet och är mer känsliga att påvisa förändringar i den subjektiva 
måendet än HHS för denna yngre grupp av patienter med lårbenshalsfraktur.  
EQ-5D är enklare att administrera och besvara än SF-36 och slutsatsen är att 
frågeformuläret EQ-5D räcker för att undersöka hälsorelaterad livskvalitet hos yngre 
patienter med lårbenshalsfraktur. 
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Markera, genom att kryssa i en ruta i varje nedanstående grupp (så här ;), vilket 
påstående som bäst beskriver Ditt hälsotillstånd i dag. 
 
 
 
Rörlighet 
Jag går utan svårigheter    
Jag kan gå men med viss svårighet    
Jag är sängliggande    
 
 
Hygien 
Jag behöver ingen hjälp med min dagliga hygien, mat eller påklädning   
Jag har vissa problem att tvätta eller klä mig själv    
Jag kan inte tvätta eller klä mig själv    
 
 
Huvudsakliga aktiviteter (t ex arbete, studier,  
hushållssysslor, familje- och fritidsaktiviteter) 
Jag klarar av mina huvudsakliga aktiviteter      
Jag har vissa problem med att klara av mina huvudsakliga aktiviteter    
Jag klarar inte av mina huvudsakliga aktiviteter    
 
 
Smärtor/besvär 
Jag har varken smärtor eller besvär    
Jag har måttliga smärtor eller besvär    
Jag har svåra smärtor eller besvär    
 
 
Oro/nedstämdhet 
Jag är inte orolig eller nedstämd    
Jag är orolig eller nedstämd i viss utsträckning    
Jag är i högsta grad orolig eller nedstämd    
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Bästa 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Sämsta 
tänkbara 
tillstånd 
0 
tänkbara 
tillstånd  
Till hjälp för att avgöra hur bra eller dåligt ett 
hälsotillstånd är, finns den termometer-liknande 
skalan till höger. På denna har Ditt bästa tänkbara 
hälsotillstånd markerats med 100 och Ditt sämsta 
tänkbara hälsotillstånd med 0. 
 
Vi vill att Du på denna skala markerar hur bra eller 
dåligt Ditt hälsotillstånd är, som Du själv bedömer 
det. Gör detta genom att dra en linje från 
nedanstående ruta till den punkt på skalan som 
markerar hur bra eller dåligt Ditt nuvarande 
hälsotillstånd är. 
 
 
 
 
 
Ditt   
nuvarande  
hälsotillstånd  
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Hälsoenkät (SF-36) 
 
Instruktion: Detta formulär innehåller frågor om hur Du ser på Din hälsa. Informationen 
skall hjälpa till att följa hur Du mår och fungerar i Ditt dagliga liv. Besvara frågorna genom 
att sätta ett kryss i den ruta Du tycker stämmer bäst in på Dig. Om Du är osäker, kryssa ändå i 
den ruta som känns riktigast. 
 
   
Utmärkt 
Mycket 
god 
 
God 
Någor-
lunda  
 
Dålig 
1 I allmänhet, skulle Du vilja säga 
att Din hälsa är: F F F F F 
 
  Mycket 
bättre nu 
än för ett 
år sedan 
Något 
bättre nu 
än för ett 
år sedan 
 
 
Ungefär 
detsamma 
Något 
sämre nu 
än för ett 
år sedan 
Mycket 
sämre nu 
än för ett 
år sedan 
2 Jämfört med för ett år sedan, hur 
skulle Du vilja bedöma Ditt 
allmänna hälsotillstånd nu? 
F F F F F 
 
 
3 De följande frågorna handlar om aktiviteter som Du kan tänkas utföra under en vanlig dag. 
Är Du på grund av Ditt hälsotillstånd begränsad i dessa aktiviteter nu? Om så är fallet, hur 
mycket ? 
  Ja, 
mycket 
begränsad 
Ja,  
lite 
begränsad 
Nej, 
inte alls 
begränsad
(a) Ansträngande aktiviteter, som att springa, lyfta tunga 
saker, delta i ansträngande sporter 
 
F F F 
(b) Måttligt ansträngande aktiviteter, som att flytta ett 
bord, dammsuga, skogspromenader eller trädgårdsarbete 
 
F F F 
(c) Lyfta eller bära matkassar 
 F F F 
(d) Gå uppför flera trappor 
 F F F 
(e) Gå uppför en trappa 
 F F F 
(f) Böja Dig eller gå ned på knä 
 F F F 
(g) Gå mer än två kilometer 
 F F F 
(h) Gå några hundra meter 
 F F F 
(i) Gå hundra meter 
 F F F 
(j) Bada eller klä på Dig F F F 
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4 Under de senaste fyra veckorna, har Du haft något av följande problem i ditt arbete 
eller med andra regelbundna dagliga aktiviteter som en följd av Ditt kroppsliga 
hälsotillstånd? 
  Ja Nej 
(a) Skurit ned den tid Du normalt ägnat åt arbete eller andra aktiviteter 
 F F 
(b) Uträttat mindre än Du skulle önskat 
 F F 
(c) Varit hindrad att utföra vissa arbetsuppgifter eller andra aktiviteter 
 F F 
(d) Haft svårigheter att utföra Ditt arbete eller andra aktiviteter 
(t ex genom att det krävde extra ansträngning) F F 
 
 
 
5 Under De senaste fyra veckorna, har Du haft något av följande problem i ditt arbete 
eller med andra regelbundna dagliga aktiviteter som en följd av känslomässiga 
problem (som t ex nedstämdhet eller ängslan)? 
  Ja Nej 
(a) Skurit ned den tid Du normalt ägnat åt arbete eller andra aktiviteter 
 F F 
(b) Uträttat mindre än Du skulle önskat 
 F F 
(c) Inte utfört arbete eller andra aktiviteter så noggrant som vanligt F F 
 
 
   
Inte alls
 
Lite 
 
Måttligt 
 
Mycket 
Väldigt 
mycket 
6 Under de senaste fyra veckorna, i 
vilken utsträckning har Ditt kroppsliga 
hälsotillstånd eller Dina känslomässiga 
problem stört Ditt vanliga umgänge 
med anhöriga, vänner, grannar eller 
andra? 
 
F F F F F 
   
Ingen 
Mycket 
lätt 
 
Lätt 
 
Måttlig 
 
Svår 
Mycket 
svår 
7 Hur mycket värk eller smärta har Du 
haft under de senaste fyra veckorna? 
 
F F F F F F 
   
Inte alls
 
Lite 
 
Måttligt 
 
Mycket 
Väldigt 
mycket 
8 Under de senaste fyra veckorna, hur 
mycket har värken eller smärtan stört 
Ditt normala arbete (innefattar både 
arbete utanför hemmet och 
hushållssysslor)? 
F F F F F 
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9 Frågorna här handlar om hur Du känner Dig och hur Du haft det under de senaste fyra veckorna. 
Ange för varje fråga det svarsalternativ som bäst beskriver hur Du känt Dig. 
 
 
Hur stor del av tiden under de senaste 
fyra veckorna… 
 
Hela 
tiden 
Största 
delen 
av tiden
En hel 
del av 
tiden 
 
En del 
av tiden 
 
Lite av 
tiden 
 
Inget 
av tiden
(a) …har Du känt Dig riktigt pigg och 
stark? F F F F F F 
(b) …har Du känt Dig mycket nervös? 
 F F F F F F 
(c) …har Du känt Dig så nedstämd att 
ingenting kunnat muntra upp Dig? F F F F F F 
(d) …har Du känt Dig lugn och 
harmonisk? F F F F F F 
(e) …har Du varit full av energi? 
 F F F F F F 
(f) …har Du känt Dig dyster och ledsen? 
 F F F F F F 
(g) …har Du känt Dig utsliten? 
 F F F F F F 
(h) …har Du känt Dig glad och lycklig? 
 F F F F F F 
(i) …har Du känt Dig trött? F F F F F F 
 
 
 
 
 
Hela 
tiden 
Största 
delen 
av tiden
 
En del 
av tiden 
 
Lite av 
tiden 
 
Inget 
av tiden
10 Under de senaste fyra veckorna, hur 
stor del av tiden har Ditt kroppsliga 
hälsotillstånd eller Dina känslomässiga 
problem stört dina möjligheter att 
umgås (t ex hälsa på släkt, vänner etc)? 
F F F F F 
 
 
11 Välj det svarsalternativ som bäst beskriver hur mycket var och ett av följande påståenden 
STÄMMER eller INTE STÄMMER in på Dig. 
   
Stämmer 
precis 
Stämmer 
ganska 
bra 
 
 
Osäker 
Stämmer 
inte sär-
skilt bra
 
Stämmer 
inte alls 
(a) Jag verkar ha lite lättare att bli sjuk än 
andra människor F F F F F 
(b) Jag är lika frisk som vem som helst av dem 
jag känner F F F F F 
(c) Jag tror min hälsa kommer att bli sämre 
 F F F F F 
(d) Min hälsa är utmärkt F F F F F 
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HOOS  
Frågeformulär för höftpatienter 
 
 
DATUM: _________________ PERSONNUMMER: ________________ 
 
 
NAMN: ____________________________________________________  
 
INSTRUKTIONER: Detta formulär innehåller frågor om hur du ser på din 
höftled. Informationen skall hjälpa till att följa hur du mår och fungerar i ditt 
dagliga liv. Besvara frågorna genom att kryssa för det alternativ du tycker 
stämmer bäst in på dig (ett alternativ för varje fråga). Om du är osäker, kryssa 
ändå för det alternativ som känns riktigast. 
 
Symptom 
Tänk på de symptom och svårigheter du haft från din höft den senaste 
veckan när du besvarar dessa frågor. 
 
S1. Har du känt att det maler i höften eller hör du klickande eller andra ljud från höften? 
 Aldrig Sällan Ibland Ofta Alltid 
           
 
S2. Svårighet att ta benen brett isär? 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
S3. Svårighet att ta ut steget när du går? 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
 
Stelhet 
Följande frågor rör ledstelhet. Stelhet innebär svårighet att komma igång eller 
ökat motstånd vid rörelser i höftleden. Ange graden av stelhet du har upplevt 
i din höft senaste veckan. 
 
S4. Hur stel har din höft varit när du just har vaknat på morgonen? 
 Inte alls Något Måttligt Mycket Extremt 
           
 
S5. Hur stel har din höft varit efter att du suttit eller legat och vilat senare under 
dagen? 
 Inte alls Något Måttligt Mycket Extremt 
           
 
Smärta 
P1. Hur ofta har du ont i höften? 
 Aldrig Varje månad Varje vecka Varje dag Alltid 
           
Appendix 3- Swedish version of the HOOS 
questionnaire 
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Följande frågor rör den höftsmärta du eventuellt upplevt den senaste veckan. 
Ange graden av smärta du har känt i följande situationer. 
 
P2. Sträcka höften helt 
 Ingen Lätt Måttlig Svår Mycket svår 
           
 
P3. Böja höften helt 
 Ingen Lätt Måttlig Svår Mycket svår 
           
 
P4. Gå på jämnt underlag 
 Ingen Lätt Måttlig Svår Mycket svår 
           
 
P5. Gå upp eller ner för trappor 
 Ingen Lätt Måttlig Svår Mycket svår
           
 
P6. Under natten i sängläge (smärta som stör sömnen) 
 Ingen Lätt Måttlig Svår Mycket svår 
           
 
P7. Sittande eller liggande 
 Ingen Lätt Måttlig Svår Mycket svår 
           
 
P8. Stående 
 Ingen Lätt Måttlig Svår Mycket svår 
           
 
P9. Gå på hårt underlag ex asfalt, betong 
 Ingen Lätt Måttlig Svår Mycket svår 
           
 
P10. Gå på ojämnt underlag 
 Ingen Lätt Måttlig Svår Mycket svår 
           
 
Fysisk funktion 
Följande frågor rör din fysiska funktion. Ange graden av svårighet du har 
upplevt den senaste veckan vid följande aktiviteter på grund av dina 
höftbesvär. 
A1. Gå nerför trappor. 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A2. Gå uppför trappor 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A3. Resa dig upp från sittande 
 Ingen Lätt Måttlig Stor Mycket stor 
           
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Ange graden av svårighet du har upplevt den senaste veckan på grund av dina 
höftbesvär. 
 
A4. Stå stilla 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A5. Böja dig, t ex för att plocka upp ett föremål från golvet 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A6. Gå på jämnt underlag 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A7. Stiga i och ur bil 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A8. Handla/göra inköp 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A9. Ta på strumpor 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A10. Stiga ur sängen 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A11. Ta av strumpor 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A12. Ligga i sängen (vända dig, hålla höften i samma läge under lång tid) 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A13. Stiga i och ur badkar/dusch 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A14. Sitta 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A15. Sätta dig och resa dig från toalettstol 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A16. Utföra tungt hushållsarbete (snöskottning, golvtvätt, dammsugning etc) 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
A17. Utföra lätt hushållsarbete (matlagning, damning etc) 
 Ingen Lätt Måttlig Stor Mycket stor 
           
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Funktion, fritid och idrott 
Följande frågor rör din fysiska förmåga. Ange graden av svårighet du upplevt 
den senaste veckan vid följande aktiviteter på grund av dina höftbesvär. 
 
SP1. Sitta på huk 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
SP2. Springa 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
SP3. Vrida/snurra på belastat ben 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
SP4. Gå på ojämnt underlag 
 Ingen Lätt Måttlig Stor Mycket stor 
           
 
Livskvalité 
 
Q1. Hur ofta gör sig din höft påmind? 
 Aldrig Varje månad Varje vecka Varje dag Alltid 
           
 
Q2. Har du förändrat ditt sätt att leva för att undvika att påfresta höften? 
 Inte alls Något Måttligt I stor utsträckning Totalt 
           
 
Q3. I hur stor utsträckning kan du lita på din höft? 
 Helt och hållet  I stor utsträckning Måttligt Till viss del Inte alls 
           
 
Q4. Hur stora problem har du med höften generellt sett? 
 Inga Små Måttliga Stora Mycket stora 
           
 
Tack för att Du tagit Dig tid att besvara samtliga frågor!. 
